New medicine launchings in India had come down during the past six years by nearly 80 per cent. The dangers associated with new-drug development were high, and for this reason, businesses were considering purchasing the molecules that were potential at relatively cheaper rates in the early stages of growth.
Aside from cutting costs, out-licensing provided chances for national players to enter into cooperation with global players. Now, with out-licensing increasing popularity in the global pharmaceutical marketplaces, among the quickest growing pharmaceutical companies in India wondered whether out-licensing might be its next large Indian opportunity. Sandeep Puri is affiliated with Institute of Management Technology, Ghaziabad
Should Natco Explore the Out-Licensing Opportunity case study solution
PUBLICATION DATE: July 20, 2015 PRODUCT #: W15303-PDF-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
University of Virginia Investment Management Company (UVIMCO)-2007
Framework for Analyzing Environmental Voluntary Agreements
Circon (A)
Knowledge Management at Andersen Consulting
Willamette Industries: No Pay at Risk Compensation
Vancouver City Savings Credit Union: Working Dads (A)
Performance Management
Movile (B): Building New Venture Opportunities
The Sandbox: Creating a Bottom-Up Entrepreneurial Ecosystem
Retail Execution: Linens ‘N Things
